Insecticides (India) targets 70% premium product mix by FY30
Management plans to shift the portfolio toward high-margin Maharatna products while trimming finance costs by up to 30% as working capital cycles normalize.
— 3 earlier stories on Insecticides (India) Ltd. →What's new
- Revenue grew 7% to ₹2,140 crore in FY26 with EBITDA margins reaching 10.6%.
- Kairos subsidiary targets revenue doubling to over ₹220 crore by FY27.
- Management expects finance costs to drop 25-30% as working capital normalizes.
Why this matters
The company is betting on a premiumization strategy to offset persistent raw material inflation. Success hinges on whether the Maharatna product mix can reach the 70% target within the promised three-to-four-year window.
What we're watching
- Impact of monsoon delays on sales following a sluggish May.
- Actual realization of the 25-30% reduction in finance costs.
- Progress on the Kairos revenue growth target for FY27.
The full read
Insecticides (India) reported ₹2,140 crore in revenue for FY26, a 7% increase, while EBITDA margins expanded to 10.6%. Management is now pivoting toward a premiumization strategy, aiming to source 70% of total sales from its high-margin Maharatna product line within the next three to four years. The company also expects finance costs to drop by 25-30% as working capital requirements normalize.
Growth plans for the Kairos subsidiary are aggressive, with a target to double revenue to over ₹220 crore by FY27. Despite these targets, the immediate outlook is tempered by persistent raw material inflation and a slow start to the season, with May sales hampered by heat waves.
It is a tall order. The company's ability to execute this premiumization shift while managing external weather risks is the primary test for the coming quarters.
Questions answered
- What is the core strategy for margin improvement?
- Management is pushing a premiumization strategy that aims to derive 70% of total sales from high-margin Maharatna products within three to four years.
- How does the company plan to lower finance costs?
- Finance costs are expected to fall by 25-30% as the company normalizes its working capital requirements.
- What are the growth targets for the Kairos subsidiary?
- The company aims to double the revenue of its Kairos subsidiary to more than ₹220 crore by fiscal 2027.
- What headwinds did management identify during the call?
- The company faces persistent raw material inflation and noted that sales in May were sluggish due to heat waves ahead of the monsoon.
Story so far
All notes on INSECTICID →- 28 May 2026 · 6:18 PM IST Insecticides (India) targets 70% premium product mix by FY30
- today Insecticides (India) reports 19% revenue growth for Q4
- today Insecticides (India) revenue climbs 7% as profit dips slightly
- today Insecticides (India) profit dips as promoter family reshuffles board